BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

483 related articles for article (PubMed ID: 29797022)

  • 1. The DPP-4 inhibitor vildagliptin impacts the gut microbiota and prevents disruption of intestinal homeostasis induced by a Western diet in mice.
    Olivares M; Neyrinck AM; Pötgens SA; Beaumont M; Salazar N; Cani PD; Bindels LB; Delzenne NM
    Diabetologia; 2018 Aug; 61(8):1838-1848. PubMed ID: 29797022
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gut-liver axis modulation in fructose-fed mice: a role for PPAR-alpha and linagliptin.
    Silva-Veiga FM; Miranda CS; Martins FF; Daleprane JB; Mandarim-de-Lacerda CA; Souza-Mello V
    J Endocrinol; 2020 Oct; 247(1):11-24. PubMed ID: 32698143
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dipeptidyl peptidase-4 inhibition ameliorates Western diet-induced hepatic steatosis and insulin resistance through hepatic lipid remodeling and modulation of hepatic mitochondrial function.
    Aroor AR; Habibi J; Ford DA; Nistala R; Lastra G; Manrique C; Dunham MM; Ford KD; Thyfault JP; Parks EJ; Sowers JR; Rector RS
    Diabetes; 2015 Jun; 64(6):1988-2001. PubMed ID: 25605806
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alteration of gut microbiota induced by DPP-4i treatment improves glucose homeostasis.
    Liao X; Song L; Zeng B; Liu B; Qiu Y; Qu H; Zheng Y; Long M; Zhou H; Wang Y; Du Y; Xu J; Shen R; Tong Q; Cai L; Li X; Guo S; Yang G; Zhu Z; Pu X; Wei H; Zheng H
    EBioMedicine; 2019 Jun; 44():665-674. PubMed ID: 30922964
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dipeptidyl peptidase IV (DPP-IV) inhibition prevents fibrosis in adipose tissue of obese mice.
    Marques AP; Cunha-Santos J; Leal H; Sousa-Ferreira L; Pereira de Almeida L; Cavadas C; Rosmaninho-Salgado J
    Biochim Biophys Acta Gen Subj; 2018 Mar; 1862(3):403-413. PubMed ID: 29154902
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ZD-2, a novel DPP4 inhibitor, protects islet β-cell and improves glycemic control in high-fat-diet-induced obese mice.
    Fan L; Yang H; Hu X; Liu J; You Y; Li X; Qin G; Ge Q; Hou Y; Xiao X
    Life Sci; 2022 Jun; 298():120515. PubMed ID: 35367243
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dipeptidyl peptidase-4 inhibition with linagliptin prevents western diet-induced vascular abnormalities in female mice.
    Manrique C; Habibi J; Aroor AR; Sowers JR; Jia G; Hayden MR; Garro M; Martinez-Lemus LA; Ramirez-Perez FI; Klein T; Meininger GA; DeMarco VG
    Cardiovasc Diabetol; 2016 Jul; 15():94. PubMed ID: 27391040
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dipeptidyl peptidase-4 (DPP-4) inhibition with linagliptin reduces western diet-induced myocardial TRAF3IP2 expression, inflammation and fibrosis in female mice.
    Aroor AR; Habibi J; Kandikattu HK; Garro-Kacher M; Barron B; Chen D; Hayden MR; Whaley-Connell A; Bender SB; Klein T; Padilla J; Sowers JR; Chandrasekar B; DeMarco VG
    Cardiovasc Diabetol; 2017 May; 16(1):61. PubMed ID: 28476142
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diet-induced obesity, energy metabolism and gut microbiota in C57BL/6J mice fed Western diets based on lean seafood or lean meat mixtures.
    Holm JB; Rønnevik A; Tastesen HS; Fjære E; Fauske KR; Liisberg U; Madsen L; Kristiansen K; Liaset B
    J Nutr Biochem; 2016 May; 31():127-36. PubMed ID: 27133432
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Suppression of gut dysbiosis reverses Western diet-induced vascular dysfunction.
    Battson ML; Lee DM; Jarrell DK; Hou S; Ecton KE; Weir TL; Gentile CL
    Am J Physiol Endocrinol Metab; 2018 May; 314(5):E468-E477. PubMed ID: 29351482
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Arctic berry extracts target the gut-liver axis to alleviate metabolic endotoxaemia, insulin resistance and hepatic steatosis in diet-induced obese mice.
    Anhê FF; Varin TV; Le Barz M; Pilon G; Dudonné S; Trottier J; St-Pierre P; Harris CS; Lucas M; Lemire M; Dewailly É; Barbier O; Desjardins Y; Roy D; Marette A
    Diabetologia; 2018 Apr; 61(4):919-931. PubMed ID: 29270816
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Peroxisome proliferator-activated receptor-alpha activation and dipeptidyl peptidase-4 inhibition target dysbiosis to treat fatty liver in obese mice.
    Silva-Veiga FM; Miranda CS; Vasques-Monteiro IML; Souza-Tavares H; Martins FF; Daleprane JB; Souza-Mello V
    World J Gastroenterol; 2022 May; 28(17):1814-1829. PubMed ID: 35633911
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protective effect of quercetin on high-fat diet-induced non-alcoholic fatty liver disease in mice is mediated by modulating intestinal microbiota imbalance and related gut-liver axis activation.
    Porras D; Nistal E; Martínez-Flórez S; Pisonero-Vaquero S; Olcoz JL; Jover R; González-Gallego J; García-Mediavilla MV; Sánchez-Campos S
    Free Radic Biol Med; 2017 Jan; 102():188-202. PubMed ID: 27890642
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Polydextrose changes the gut microbiome and attenuates fasting triglyceride and cholesterol levels in Western diet fed mice.
    Raza GS; Putaala H; Hibberd AA; Alhoniemi E; Tiihonen K; Mäkelä KA; Herzig KH
    Sci Rep; 2017 Jul; 7(1):5294. PubMed ID: 28706193
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dipeptidyl peptidase inhibition prevents diastolic dysfunction and reduces myocardial fibrosis in a mouse model of Western diet induced obesity.
    Bostick B; Habibi J; Ma L; Aroor A; Rehmer N; Hayden MR; Sowers JR
    Metabolism; 2014 Aug; 63(8):1000-11. PubMed ID: 24933400
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A polyphenol-rich cranberry extract protects from diet-induced obesity, insulin resistance and intestinal inflammation in association with increased Akkermansia spp. population in the gut microbiota of mice.
    Anhê FF; Roy D; Pilon G; Dudonné S; Matamoros S; Varin TV; Garofalo C; Moine Q; Desjardins Y; Levy E; Marette A
    Gut; 2015 Jun; 64(6):872-83. PubMed ID: 25080446
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An increase in the Akkermansia spp. population induced by metformin treatment improves glucose homeostasis in diet-induced obese mice.
    Shin NR; Lee JC; Lee HY; Kim MS; Whon TW; Lee MS; Bae JW
    Gut; 2014 May; 63(5):727-35. PubMed ID: 23804561
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hepatic Dipeptidyl Peptidase-4 Controls Pharmacokinetics of Vildagliptin In Vivo.
    Asakura M; Fukami T; Nakajima M; Fujii H; Atsuda K; Itoh T; Fujiwara R
    Drug Metab Dispos; 2017 Feb; 45(2):237-245. PubMed ID: 27895112
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vildagliptin increases butyrate-producing bacteria in the gut of diabetic rats.
    Zhang Q; Xiao X; Li M; Yu M; Ping F; Zheng J; Wang T; Wang X
    PLoS One; 2017; 12(10):e0184735. PubMed ID: 29036231
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Western diet induces colonic nitrergic myenteric neuropathy and dysmotility in mice via saturated fatty acid- and lipopolysaccharide-induced TLR4 signalling.
    Reichardt F; Chassaing B; Nezami BG; Li G; Tabatabavakili S; Mwangi S; Uppal K; Liang B; Vijay-Kumar M; Jones D; Gewirtz AT; Srinivasan S
    J Physiol; 2017 Mar; 595(5):1831-1846. PubMed ID: 28000223
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.